Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Life Science Equipment

Myriad Genetics Inc

+ Add to Watchlist

MYGN:US

34.4700 USD 0.0200 0.06%

As of 20:10:00 ET on 05/21/2015.

Snapshot for Myriad Genetics Inc (MYGN)

Open: 34.5700 Day's Range: 34.3700 - 34.8700 Volume: 458,534
Previous Close: 34.4500 52wk Range: 31.5600 - 40.5000 1-Yr Rtn: +3.42%

Stock Chart for MYGN

No chart data available.
  • MYGN:US 34.5200
  • 1D
  • 1M
  • 1Y
34.4500
Interactive MYGN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MYGN

Current P/E Ratio (ttm) 25.3992
Estimated P/E(06/2015) 23.7724
Relative P/E vs. SPX 1.3491
Earnings Per Share (USD) (ttm) 1.3571
Est. EPS (USD) (06/2015) 1.4500
Est. PEG Ratio 1.7469
Market Cap (M USD) 2,393.98
Shares Outstanding (M) 69.45
30 Day Average Volume 756,085
Price/Book (mrq) 3.6084
Price/Sale (ttm) 3.4649
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/12/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MYGN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for MYGN

Myriad Genetics, Inc. develops and markets molecular diagnostic products to provide physicians with information to help guide the care of their patients, to prevent disease, delay the onset of disease, or catch disease at an early stage.

Peter D MeldrumPresident/CEO/Co-FounderRobert Gardner HarrisonChief Information Officer
Jerry S LanchburyChief Scientific OfficerR Bryan RiggsbeeExec VP/CFO/Treasurer
More Company Profile & Key Executives for MYGN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil